Moneycontrol PRO
Live: Live | How To Build Your Portfolio Amid Recession Jitters?
you are here: HomeNewsTrendsHealth

Risk of vaccine-resistant variants highest when most jabbed: Study

At a time when nearly 60 percent of Europeans have received at least one vaccine dose, the authors said their modelling study showed the need to maintain non-vaccination measures until everyone is fully jabbed.

July 30, 2021 / 03:20 PM IST

Relaxing restrictions like mask-wearing and social distancing when most people have been vaccinated greatly increases the risk of vaccine-resistant variants of the virus that causes COVID-19, new research showed on Friday.

At a time when nearly 60 percent of Europeans have received at least one vaccine dose, the authors said their modelling study showed the need to maintain non-vaccination measures until everyone is fully jabbed.

To predict how the SARS-CoV-2 virus might mutate in response to vaccination campaigns, a pan-European team of experts simulated the probability of a vaccine-resistant strain emerging in a population of 10 million people over three years.

Variables included vaccination, mutation and transmission rates -- including recurring "waves" of infections and falls in cases in response to lockdowns.

Follow our LIVE blog for latest updates of the novel coronavirus pandemic

Close

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

Predictably, the model showed that a rapid rate of vaccination reduced the risk of a resistant strain emerging.

But in what the authors called a "counterintuitive result", the model showed that the highest risk of resistant strains emerging came when a large proportion of the population was vaccinated, but not large enough to ensure herd immunity.

This is in essence where much of Europe is currently, where the Delta variant is spreading rapidly.

The authors said the model showed a threshold of 60 percent of the population vaccinated, after which resistant variants were more likely to occur.

"Vaccines are our best bet to beat this pandemic" said co-author Simon Rella, from Austria's Institute of Science and Technology (IST).

"What our model showed is that when most people are vaccinated, the vaccine-resistant strain has an advantage over the original strain.

"This means that the vaccine-resistant strain spreads through the population faster than the original strain at a time when most people are vaccinated," Rella told journalists in an online briefing.

Evolution is powerful

Authors said that their research highlighted the need to maintain other anti-COVID measures until everyone is vaccinated.

"Of course we hope that vaccine-resistance does not evolve over the course of this pandemic, but we urge caution," said Fyodor Kondrashov, a IST researcher and study co-author.

"Evolution is a very powerful force and maintaining some reasonable precautions throughout the whole vaccination period may actually be a good tool to control this evolution."

Currently just over one billion people around the world are fully vaccinated against COVID-19, with many countries -- particularly in Africa and South America -- yet to start widespread rollouts due to lack of supply.

"Without global coordination, vaccine resistant strains may be eliminated in some populations but could persist in others," said the study, published in Nature Scientific Reports.

"Thus, a truly global vaccination effort may be necessary to reduce the chances of a global spread of a resistant strain."

Follow our full coverage of the coronavirus pandemic here.
AFP
first published: Jul 30, 2021 03:20 pm
Sections
ISO 27001 - BSI Assurance Mark